During the last session, CorMedix Inc (NASDAQ:CRMD)’s traded shares were 1.49 million, with the beta value of the company hitting 1.72. At the end of the trading day, the stock’s price was $11.71, reflecting an intraday gain of 3.17% or $0.36. The 52-week high for the CRMD share is $17.43, that puts it down -48.85 from that peak though still a striking 69.17% gain since the share price plummeted to a 52-week low of $3.61. The company’s market capitalization is $871.56M, and the average intraday trading volume over the past 10 days was 2.57 million shares, and the average trade volume was 1.97 million shares over the past three months.
CorMedix Inc (CRMD) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.29. CRMD has a Sell rating from 1 analyst(s) out of 2 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it.
CorMedix Inc (NASDAQ:CRMD) trade information
CorMedix Inc (CRMD) registered a 3.17% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 3.17% in intraday trading to $11.71, hitting a weekly high. The stock’s 5-day price performance is 1.04%, and it has moved by -18.40% in 30 days. Based on these gigs, the overall price performance for the year is 44.57%. The short interest in CorMedix Inc (NASDAQ:CRMD) is 8.59 million shares and it means that shorts have 6.18 day(s) to cover.
The consensus price target of analysts on Wall Street is $9, which implies a decrease of -30.11% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $9 and $9 respectively. As a result, CRMD is trading at a premium of 23.14% off the target high and 23.14% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 29.80%. While earnings are projected to return 455.24% in 2025.
CRMD Dividends
CorMedix Inc is due to release its next quarterly earnings on 2025-May-06. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
CorMedix Inc (NASDAQ:CRMD)’s Major holders
CorMedix Inc insiders own 1.19% of total outstanding shares while institutional holders control 37.18%, with the float percentage being 37.63%. BLACKROCK INC. is the largest shareholder of the company, while 186.0 institutions own stock in it. As of 2024-06-30, the company held over 3.55 million shares (or 6.167% of all shares), a total value of $15.39 million in shares.
The next largest institutional holding, with 2.9 million shares, is of VANGUARD GROUP INC’s that is approximately 5.0373% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $12.57 million.
Also, the Mutual Funds coming in first place with the largest holdings of CorMedix Inc (CRMD) shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF . Data provided on Mar 31, 2025 indicates that VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund owns about 1.98 shares. This amounts to just over 2.92 percent of the company’s overall shares, with a $23.17 million market value. The same data shows that the other fund manager holds slightly less at 1.52, or about 2.24% of the stock, which is worth about $17.76 million.
